The FOCUS system automates OCT retina diagnosis end to end and matches expert accuracy.
Chengdu-based Beyang Therapeutics closes an oversubscribed Series A to fund AI-designed retinal disease and leukemia candidates.
OCTCube-M reads full volumetric OCT scans to improve retinal disease detection, cut trial sizes and open a window to systemic…